Chardan Healthcare Acquisition 2 Corp.

If you purchased Chardan Healthcare Acquisition 2 Corp. securities and would like to join the action, please click "Join This Action" below.

CHARDAN HEALTHCARE MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE MERGER OF CHARDAN HEALTHCARE ACQUISITION 2 CORP. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – CHAQ

April 28, 2021.

New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) and Renovacor, Inc. is fair to Chardan Healthcare shareholders.

The investigation concerns whether Chardan Healthcare and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Chardan Healthcare shareholders; and (2) disclose all material information necessary for Chardan Healthcare shareholders to adequately assess and value the merger consideration. On behalf of Chardan Healthcare shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Certification

Scroll to Top